NCP «BIOTECHNOLOGY»
Russian National Contact Point «Food security, sustainable agriculture, marine and maritime research and the bio-economy & Biotechnology»
Russian National Contact Point «Food security, sustainable agriculture, marine and maritime research and the bio-economy & Biotechnology»
Vladimir Putin has declared 2021 as the the Year of Science and Technology
"The challenge of the epidemic that civilization faced very clearly, convincingly showed the enormous significance of those areas that determine security, the quality of human life," Putin said, noting that we are talking about health care, education, ecology, as well as science and technology.
"The challenge of the epidemic that civilization faced very clearly, convincingly showed the enormous significance of those areas that determine security, the quality of human life," Putin said, noting that we are talking about health care, education, ecology, as well as science and technology.
HUNGARY BECOMES THE FIRST COUNTRY IN EU TO AUTHORIZE THE SPUTNIK V VACCINE
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the Sputnik V vaccine has been approved by the National Institute of Pharmacy and Nutrition of Hungary (OGYÉI).
Thus Hungary has become the first country in the European Union to authorize the use of Sputnik V. The vaccine was approved under the emergency use authorization procedure. The approval is based on the results of the clinical trials of Sputnik V in Russia and a comprehensive assessment of the vaccine by experts in Hungary.
Sputnik V had been registered earlier under the same procedure in Algeria, Argentina, Bolivia, Serbia, Palestine, Venezuela, Paraguay and Turkmenistan. The vaccine is also registered in Russia and Belarus.
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the Sputnik V vaccine has been approved by the National Institute of Pharmacy and Nutrition of Hungary (OGYÉI).
Thus Hungary has become the first country in the European Union to authorize the use of Sputnik V. The vaccine was approved under the emergency use authorization procedure. The approval is based on the results of the clinical trials of Sputnik V in Russia and a comprehensive assessment of the vaccine by experts in Hungary.
Sputnik V had been registered earlier under the same procedure in Algeria, Argentina, Bolivia, Serbia, Palestine, Venezuela, Paraguay and Turkmenistan. The vaccine is also registered in Russia and Belarus.
Sputnik V - Russia is fifth on the list of vaccine makers
(Bloomberg Opinion) -- When it comes to Covid-19 vaccines, a lot of attention seems to have centered on the ones being made in the West. So it may come as a surprise that Russia is fifth on the list of vaccine makers with the most doses under contract through pre-purchase agreements, according to Bloomberg’s Covid-19 Vaccine Tracker. The shot — whimsically named Sputnik V and developed by the Gamaleya institute — is just behind GlaxoSmithKline Plc and Sanofi’s candidate in the rankings and ahead of the shots developed by Moderna Inc. and Johnson & Johnson. This is notable for a vaccine that has yet to be featured in any peer-reviewed scientific journal. How do we know we can trust it?
(Bloomberg Opinion) -- When it comes to Covid-19 vaccines, a lot of attention seems to have centered on the ones being made in the West. So it may come as a surprise that Russia is fifth on the list of vaccine makers with the most doses under contract through pre-purchase agreements, according to Bloomberg’s Covid-19 Vaccine Tracker. The shot — whimsically named Sputnik V and developed by the Gamaleya institute — is just behind GlaxoSmithKline Plc and Sanofi’s candidate in the rankings and ahead of the shots developed by Moderna Inc. and Johnson & Johnson. This is notable for a vaccine that has yet to be featured in any peer-reviewed scientific journal. How do we know we can trust it?
The 27th IraSME call
The 27th IraSME call for proposals for transnational R&D projects has opened in November 2020. The call is organised and funded by national and regional ministries and agencies participating in the IraSME network through their respective funding programmes.
When applying for this call for proposals, please note that applicants are required to consult with their local agencies at an early stage during the preparation of their proposals in order to secure compliance with the applicable national and regional criteria. Eligibility rules, application and funding details vary between countries/regions.
Deadline for Russian participants: 14.04.2021 ãîäà.
The 27th IraSME call for proposals for transnational R&D projects has opened in November 2020. The call is organised and funded by national and regional ministries and agencies participating in the IraSME network through their respective funding programmes.
When applying for this call for proposals, please note that applicants are required to consult with their local agencies at an early stage during the preparation of their proposals in order to secure compliance with the applicable national and regional criteria. Eligibility rules, application and funding details vary between countries/regions.
Deadline for Russian participants: 14.04.2021 ãîäà.
Call for the best fundamental scientific research projects, conducted jointly by the Russian Foundation for Basic Research and the Austrian Scientific Foundation
The task of the Contest is to support fundamental scientific research, to develop international cooperation in the field of basic scientific research, to promote the inclusion of Russian scientists in the world scientific community, and to create conditions for the implementation of joint scientific projects by scientists from Russia and Austria.
The task of the Contest is to support fundamental scientific research, to develop international cooperation in the field of basic scientific research, to promote the inclusion of Russian scientists in the world scientific community, and to create conditions for the implementation of joint scientific projects by scientists from Russia and Austria.
Partners
